Health and Fitness Health and Fitness
Tue, August 7, 2012
Mon, August 6, 2012
Fri, August 3, 2012
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
00 p.m. EDT
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Head of European Operations
Tue, July 31, 2012
Mon, July 30, 2012
Sun, July 29, 2012
Fri, July 27, 2012
Thu, July 26, 2012
Wed, July 25, 2012
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results
Mon, July 23, 2012
Sun, July 22, 2012
Sat, July 21, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012

Cytori to Webcast Second Quarter Financial Results on August 8


Published on 2012-07-26 05:16:41 - Market Wire
  Print publication without navigation


July 26, 2012 08:00 ET

Cytori to Webcast Second Quarter Financial Results on August 8

SAN DIEGO, CA--(Marketwire - Jul 26, 2012) - Cytori Therapeutics (NASDAQ: [ CYTX ]) will provide a live webcast of its second quarter financial results and business update on Wednesday, August 8, 2012 at 5:00 PM Eastern Time.

The dial-in information is as follows:

Dial-In Number: +1.866.791.6247
Passcode: 4549443

Prior to the webcast at approximately 4:05 PM Eastern Time on August 8, Cytori will issue its second quarter earnings release and post a quarterly shareholder letter to its Investor Relations homepage, which will review Cytori's second quarter performance.

The webcast will be available both live and by replay two hours after the call under "Webcasts" on the Company's Investor Relations website ([ http://ir.cytori.com ]).

About Cytori

Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution® System product family. [ www.cytori.com ]



Publication Contributing Sources